Questions a plan sponsor actually asks.
What is Emtricitabine and Tenofovir Disoproxil used for?
Emtricitabine and Tenofovir Disoproxil blocks HIV replication by inhibiting reverse transcriptase.
Is there a generic for Emtricitabine and Tenofovir Disoproxil?
Yes. 22 ANDAs filed at FDA, 10 generic manufacturers currently shipping.
How much does my plan pay for Emtricitabine and Tenofovir Disoproxil?
Across 329 Part D plans, Emtricitabine and Tenofovir Disoproxil averages $5.37/unit (NADAC). Lowest available: $0.457/unit. Highest in distribution: $59.79/unit.
Is Emtricitabine and Tenofovir Disoproxil on the FDA shortage list?
No. Emtricitabine and Tenofovir Disoproxil is not currently on the FDA Drug Shortage Database.
7 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Same class. Different math.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (18 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.